On June 15, 2024, an expert council was held in Moscow on the topic: «The Place of Topical Combined Multicomponent Drugs in the Treatment of Complicated Dermatoses.» The council became the basis for discussing the accumulated clinical and organizational problems in the field of using multicomponent drugs in algorithms for managing patients with dermatoses of combined etiology, with concomitant visceral or cutaneous comorbidity, the influence of exposome factors on the course of steroid-sensitive, potentially complicated skin diseases. The council discussed the feasibility of prescribing multicomponent drugs in patients with altered skin microbiome against the background of dermatoses, taking into account the risk factors for the addition of a secondary infection. The prerequisites for creating a modern algorithm for the use and the place of a three-component drug produced using micronization technology, containing betamethasone, gentamicin and clotrimazole, as part of the complex therapy of chronic inflammatory itchy skin diseases were discussed.